Objectionable Microorganisms in Medicinal Products - Aseptic Environment 2013
24 Jan 2013
Webinar
Key Topics
FDA regulations
Review of recall data
ICH guidelines
FDA guidance on Aseptic Processing
Risk assessment of the presence of microorganisms in the aseptic environment and its impact on product
Definitions of "objectionable microorganisms"
Who should Attend
Delegates involved in Quality system auditors, Manufacturing, Microbiology analysts and technicians, QA directors and managers, Regulatory and Compliance Management and Consultants.
Past Events
Objectionable Microorganisms in Medicinal Products - Aseptic Environment 2013 - 24 Jan 2013, Webinar (35043)
Objectionable Microorganisms in Medicinal Products - Aseptic Environment 2026
Important
Please, check "Objectionable Microorganisms in Medicinal Products - Aseptic Environment" official website for possible changes, before making any traveling arrangements
